VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹64 Cr | ₹60 Cr | ₹60 Cr | ₹62 Cr | ₹54 Cr |
What is the latest Operating Profit of VENUS REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹64 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹60 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹54 Cr |
How is Operating Profit of VENUS REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹64 Cr | 6.59 | |
| Mar2024 | ₹60 Cr | -0.71 | |
| Mar2023 | ₹60 Cr | -3.36 | |
| Mar2022 | ₹62 Cr | 15.50 | |
| Mar2021 | ₹54 Cr | - | |
Compare Operating Profit of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,607.5 Cr | 5.2% | 63% | 311% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,792.0 Cr | 2.8% | 1.8% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,152.0 Cr | -0.2% | -0.1% | 3.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,915.0 Cr | 1.4% | -1.5% | 39.9% | Stock Analytics | |
| CIPLA | ₹116,354.0 Cr | 6% | 1.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,681.0 Cr | 4.8% | -0.3% | -0.9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 5.2% |
63% |
311% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses